Margariti A, Zeng L, Xu Q
Department of Cardiac and Vascular Sciences, St George's, University of London, Cranmer Terrace, London, UK.
Histol Histopathol. 2006 Sep;21(9):979-85. doi: 10.14670/HH-21.979.
Stem cells have the ability to differentiate into a variety of cells to replace dead cells or to repair tissue. Recently, accumulating evidence indicates that mechanical forces, cytokines and other factors can influence stem cell differentiation into vascular smooth muscle cells (SMCs). In developmental process, SMCs originate from several sources, which show a great heterogenicity in different vessel walls. In adult vessels, SMCs display a less proliferative nature, but are altered in response to risk factors for atherosclerosis. Traditional view on SMC origins in atherosclerotic lesions is challenged by the recent findings that stem cells and smooth muscle progenitors contribute to the development of atherosclerotic lesions. Vascular progenitor cells circulating in human blood and the presence of adventitia in animals are recent discoveries, but the source of these cells is still unknown. The present review gives an update on the progress of stem cell and SMC research in atherosclerosis, and discusses possible mechanisms of stem/progenitor cell differentiation that contribute to the disease process.
干细胞具有分化为多种细胞的能力,以替代死亡细胞或修复组织。最近,越来越多的证据表明,机械力、细胞因子和其他因素可影响干细胞向血管平滑肌细胞(SMC)的分化。在发育过程中,SMC起源于多个来源,在不同血管壁中表现出很大的异质性。在成人血管中,SMC增殖性较低,但会因动脉粥样硬化的危险因素而发生改变。最近的研究发现干细胞和平滑肌祖细胞参与动脉粥样硬化病变的发展,这对传统的关于动脉粥样硬化病变中SMC起源的观点提出了挑战。循环在人体血液中的血管祖细胞以及动物中外膜的存在是最近的发现,但这些细胞的来源仍然未知。本综述介绍了动脉粥样硬化中干细胞和SMC研究的进展,并讨论了干细胞/祖细胞分化可能导致疾病进程的机制。